No difference in striatal dopamine transporter availability between active smokers, ex-smokers and non-smokers using [123I]FP-CIT (DaTSCAN) and SPECT

EJNMMI Research

Volumn 3, Issue 1, 2013, Pages 1-7

  Thomsen, Gerda ^a   Knudsen, Gitte Moos ^a   Jensen, Peter S ^a   Ziebell, Morten ^a   Holst, Klaus K ^a,o   Asenbaum, Susanne ^b   Booij, Jan ^c   Darcourt, Jacques ^d   Dickson, John C ^e   Kapucu, Özlem L ^f   Nobili, Flavio ^g   Sabri, Osama ^h   Sera, Terez ⁱ   Tatsch, Klaus ^j   Tossici Bolt, Livia ^k   van Laere, Koen ^l   Borght, Thierry Vander ^m   Varrone, Andrea ⁿ   Pagani, Marco ⁿ   Pinborg, Lars Hageman ^a  

^a Mental Health Center Glostrup   (Denmark)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d CENTRE ANTOINE LACASSAGNE   (France)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

^f GAZI UNIVERSITY   (Turkey)

^g UNIVERSITY OF GENOA   (Italy)

^h UNIVERSITY OF LEIPZIG   (Germany)

ⁱ UNIVERSITY OF SZEGED   (Hungary)

^j Municipal Hospital Karlsruhe   (Germany)

^k UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^l UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^m UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

ⁿ KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^o UNIVERSITY OF COPENHAGEN   (Denmark)

more..

Author keywords

Dopamine transporter; Non smoking; SPECT; Tobacco smoking

Indexed keywords

DOPAMINE TRANSPORTER; IOFLUPANE I 123;

ADULT; AGED; ARTICLE; ENZYME ACTIVITY; EUROPEAN UNION; FEMALE; HUMAN; HUMAN EXPERIMENT; IMAGE ANALYSIS; MALE; MOLECULAR IMAGING; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SMOKING;

EID: 84878804326     PISSN: None     EISSN: 2191219X     Source Type: Journal    
DOI: 10.1186/2191-219X-3-39     Document Type: Article

References (43)

1. Pontieri FE, Tanda G, Orzi F, Di CG: Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature 1996, 382:255-257.
2. Di CG, Imperato A: Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. J Pharmacol Exp Ther 1988, 244:1067-1080.
3. Damsma G, Day J, Fibiger HC: Lack of tolerance to nicotine-induced dopamine release in the nucleus accumbens. Eur J Pharmacol 1989, 168:363-368.
4. Sziraki LMN, Hashim A, Sershen H, Allen D, Cooper T, Czobor P, Lajtha A: Differences in nicotine-induced dopamine release and nicotine pharmacokinetics between Lewis and Fischer 344 rats. Neurochem Res 2001, 26:609-617.
5. Dewey SL, Brodie JD, Gerasimov M, Horan B, Gardner EL, Ashby CR Jr: A pharmacologic strategy for the treatment of nicotine addiction. Synapse 1999, 31:76-86.
6. Tsukada H, Miyasato K, Kakiuchi T, Nishiyama S, Harada N, Domino EF: Comparative effects of methamphetamine and nicotine on the striatal [(11) C]raclopride binding in unanesthetized monkeys. Synapse 2002, 45:207-212.
7. Cumming P, Rosa-Neto P, Watanabe H, Smith D, Bender D, Clarke PB, Gjedde A: Effects of acute nicotine on hemodynamics and binding of [11C]raclopride to dopamine D2,3 receptors in pig brain. Neuroimage 2003, 19:1127-1136.
8. Marenco S, Carson RE, Berman KF, Herscovitch P, Weinberger DR: Nicotine-induced dopamine release in primates measured with [11C] raclopride PET. Neuropsychopharmacology 2004, 29:259-268.
9. Brody AL, Olmstead RE, London ED, Farahi J, Meyer JH, Grossman P, Lee GS, Huang J, Hahn EL, Mandelkern MA: Smoking-induced ventral striatum dopamine release. Am J Psychiatry 2004, 161:1211-1218.
10. Brody AL: Functional brain imaging of tobacco use and dependence. J Psychiatr Res 2006, 40:404-418.
11. Brody AL, Mandelkern MA, Olmstead RE, Len-Martinez Z, Scheibal D, Abrams AL, Costello MR, Farahi J, Saxena S, Monterosso J, London ED: Ventral striatal dopamine release in response to smoking a regular vs a denicotinized cigarette. Neuropsychopharmacology 2009, 34:282-289.
12. Scott DJ, Domino EF, Heitzeg MM, Koeppe RA, Ni L, Guthrie S, Zubieta JK: Smoking modulation of mu-opioid and dopamine D2 receptor-mediated neurotransmission in humans. Neuropsychopharmacology 2007, 32:450-457.
13. Takahashi H, Fujimura Y, Hayashi M, Takano H, Kato M, Okubo Y, Kanno I, Ito H, Suhara T: Enhanced dopamine release by nicotine in cigarette smokers: a double-blind, randomized, placebo-controlled pilot study. Int J Neuropsychopharmacol 2008, 11:413-417.
14. Barrett SP, Boileau I, Okker J, Pihl RO, Dagher A: The hedonic response to cigarette smoking is proportional to dopamine release in the human striatum as measured by positron emission tomography and [11C] raclopride. Synapse 2004, 54:65-71.
15. Montgomery AJ, Lingford-Hughes AR, Egerton A, Nutt DJ, Grasby PM: The effect of nicotine on striatal dopamine release in man: a [11C]raclopride PET study. Synapse 2007, 61:637-645.
16. Volkow ND, Fowler JS, Gatley SJ, Dewey SL, Wang GJ, Logan J, Ding YS, Franceschi D, Gifford A, Morgan A, Pappas N, King P: Comparable changes in synaptic dopamine induced by methylphenidate and by cocaine in the baboon brain. Synapse 1999, 31:59-66.
17. Carson RE, Breier A, De BA, Saunders RC, Su TP, Schmall B, Der MG, Pickar D, Eckelman WC: Quantification of amphetamine-induced changes in [11C] raclopride binding with continuous infusion. J Cereb Blood Flow Metab 1997, 17:437-447.
18. Hartvig P, Torstenson R, Tedroff J, Watanabe Y, Fasth KJ, Bjurling P, Langstrom B: Amphetamine effects on dopamine release and synthesis rate studied in the Rhesus monkey brain by positron emission tomography. J Neural Transm 1997, 104:329-339.
19. Drevets WC, Price JC, Kupfer DJ, Kinahan PE, Lopresti B, Holt D, Mathis C: PET measures of amphetamine-induced dopamine release in ventral versus dorsal striatum. Neuropsychopharmacology 1999, 21:694-709.
20. Ziebell M, Thomsen G, Knudsen GM, De NR, Svarer C, Wagner A, Pinborg LH: Reproducibility of [123I]PE2I binding to dopamine transporters with SPECT. Eur J Nucl Med Mol Imaging 2007, 34:101-109.
21. Booij J, Habraken JB, Bergmans P, Tissingh G, Winogrodzka A, Wolters EC, Janssen AG, Stoof JC, van Royen EA: Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson's disease. J Nucl Med 1998, 39:1879-1884.
22. DeLorenzo C, Kumar JS, Zanderigo F, Mann JJ, Parsey RV: Modeling considerations for in vivo quantification of the dopamine transporter using [(11)C]PE2I and positron emission tomography. J Cereb Blood Flow Metab 2009, 29:1332-1345.
23. Picciotto MR, Zoli M, Rimondini R, Lena C, Marubio LM, Pich EM, Fuxe K, Changeux JP: Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine. Nature 1998, 391:173-177.
24. Chen Y, Sharples TJ, Phillips KG, Benedetti G, Broad LM, Zwart R, Sher E: The nicotinic alpha 4 beta 2 receptor selective agonist, TC-2559, increases dopamine neuronal activity in the ventral tegmental area of rat midbrain slices. Neuropharmacology 2003, 45:334-344.
25. Fehr C, Yakushev I, Hohmann N, Buchholz HG, Landvogt C, Deckers H, Eberhardt A, Klager M, Smolka MN, Scheurich A, Dielentheis T, Schmidt LG, Rosch F, Bartenstein P, Grunder G, Schreckenberger M: Association of low striatal dopamine d2 receptor availability with nicotine dependence similar to that seen with other drugs of abuse. Am J Psychiatry 2008, 165:507-514.
26. Brown AK, Mandelkern MA, Farahi J, Robertson C, Ghahremani DG, Sumerel B, Moallem N, London ED: Sex differences in striatal dopamine D2/D3 receptor availability in smokers and non-smokers. Int J Neuropsychopharmacol 2012, 15:989-994.
27. Yang YK, Yao WJ, McEvoy JP, Chu CL, Lee IH, Chen PS, Yeh TL, Chiu NT: Striatal dopamine D2/D3 receptor availability in male smokers. Psychiatry Res 2006, 146:87-90.
28. Yang YK, Yao WJ, Yeh TL, Lee IH, Chen PS, Lu RB, Chiu NT: Decreased dopamine transporter availability in male smokers-a dual isotope SPECT study. Prog Neuropsychopharmacol Biol Psychiatry 2008, 32:274-279.
29. Danielson K, Truman P, Kivell BM: The effects of nicotine and cigarette smoke on the monoamine transporters. Synapse 2011, 65:866-879.
30. Carr LA, Rowell PP, Pierce WM Jr: Effects of subchronic nicotine administration on central dopaminergic mechanisms in the rat. Neurochem Res 1989, 14:511-515.
31. Yamashita H, Kitayama S, Zhang YX, Takahashi T, Dohi T, Nakamura S: Effect of nicotine on dopamine uptake in COS cells possessing the rat dopamine transporter and in PC12 cells. Biochem Pharmacol 1995, 49:742-745.
32. Zhu J, Reith ME: Role of the dopamine transporter in the action of psychostimulants, nicotine, and other drugs of abuse. CNS Neurol Disord Drug Targets 2008, 7:393-409.
33. Newberg A, Lerman C, Wintering N, Ploessl K, Mozley PD: Dopamine transporter binding in smokers and nonsmokers. Clin Nucl Med 2007, 32:452-455.
34. Erritzoe D, Frokjaer VG, Haugbol S, Marner L, Svarer C, Holst K, Baare WF, Rasmussen PM, Madsen J, Paulson OB, Knudsen GM: Brain serotonin 2A receptor binding: relations to body mass index, tobacco and alcohol use. Neuroimage 2009, 46:23-30.
35. Tossici-Bolt L, Dickson JC, Sera T, De NR, Bagnara MC, Jonsson C, Scheepers E, Zito F, Seese A, Koulibaly PM, Kapucu OL, Koole M, Raith M, George J, Lonsdale MN, Munzing W, Tatsch K, Varrone A: Calibration of gamma camera systems for a multicentre European (1)(2)(3)I-FP-CIT SPECT normal database. Eur J Nucl Med Mol Imaging 2011, 38:1529-1540.
36. Dickson JC, Tossici-Bolt L, Sera T, Erlandsson K, Varrone A, Tatsch K, Hutton BF: The impact of reconstruction method on the quantification of DaTSCAN images. Eur J Nucl Med Mol Imaging 2010, 37:23-35.
37. Dickson JC, Tossici-Bolt L, Sera T, De NR, Booij J, Bagnara MC, Seese A, Koulibaly PM, Akdemir UO, Jonsson C, Koole M, Raith M, Lonsdale MN, George J, Zito F, Tatsch K: Proposal for the standardisation of multi-centre trials in nuclear medicine imaging: prerequisites for a European 123I-FP-CIT SPECT database. Eur J Nucl Med Mol Imaging 2012, 39:188-197.
38. Jensen PS, Ziebell M, Skouboe G, Khalid U, De NR, Thomsen G, Knudsen GM, Svarer C: Validation of a method for accurate and highly reproducible quantification of brain dopamine transporter SPECT studies. J Nucl Med Technol 2011, 39:271-278.
39. R Core Team: R: A Language and Environment for Statistical Computing. Vienna: R Foundation for Statistical Computing; 2012.
40. van Dyck CH, Seibyl JP, Malison RT, Laruelle M, Zoghbi SS, Baldwin RM, Innis RB: Age-related decline in dopamine transporters: analysis of striatal subregions, nonlinear effects, and hemispheric asymmetries. Am J Geriatr Psychiatry 2002, 10:36-43.
41. Staley JK, Krishnan-Sarin S, Zoghbi S, Tamagnan G, Fujita M, Seibyl JP, Maciejewski PK, O'Malley S, Innis RB: Sex differences in [123I]beta-CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers. Synapse 2001, 41:275-284.
42. Salokangas RK, Vilkman H, Ilonen T, Taiminen T, Bergman J, Haaparanta M, Solin O, Alanen A, Syvalahti E, Hietala J: High levels of dopamine activity in the basal ganglia of cigarette smokers. Am J Psychiatry 2000, 157:632-634.
43. Gjedde A, Reith J, Dyve S, Leger G, Guttman M, Diksic M, Evans A, Kuwabara H: Dopa decarboxylase activity of the living human brain. Proc Natl Acad Sci U S A 1991, 88:2721-2725.